AIP and atopic eczema: We recently showed that agr inhibition by AIP-like molecules reduces S. aureus induced lesions in an atopic dermatitis model (Baldry et al., 2018) and this was supported by the finding that CoNS strains reduce skin barrier damage by inhibiting production of proteases and phenol-soluble modulins secreted by S. aureus (Williams et al., 2019).